In summary, we identified an association between BC-MGA and germline pathogenic/likely pathogenic variants (P/LPVs) in HRD-associated genes, particularly in BRCA1. While IBC-MGA in germline and sporadic contexts shares similar clinical features, these findings may have important implications for future treatment strategies and personalized medicine approaches. This evidence concerns the gene BRCA1 and inflammatory breast carcinoma.